This vertically integrated pharmaceutical company specializes in developing, manufacturing, and marketing a wide range of products across multiple therapeutic areas. Their key focus areas include oncology, blood-related products, nephrology, cardiology, gynecology, diabetology, and beta-lactam cephalosporins, along with vitamins and minerals. They also offer nutraceuticals and herbal products. The company's product portfolio encompasses various dosage forms such as injectables, suppositories, tablets, capsules, suspensions, syrups, ointments, emulsions, elixirs, ophthalmics, effervescent tablets, and dry powder. They have a strong global presence, participating in prominent industry events across regions like Europe and the Middle East. The company prioritizes quality and adheres to GMP certifications, further bolstering their commitment to delivering reliable pharmaceutical solutions.

This CTD dossier owner and manufacturer, established over three decades ago in South Asia, has become a prominent player in the global pharmaceutical market. Their focus lies in manufacturing and exporting a wide array of pharmaceutical products, including prescription and over-the-counter medications, to regulated and non-regulated markets worldwide. They have a strong presence in regions like Latin America, the Middle East, CIS, and Asia, with a subsidiary established in the Caucasus. Their commitment to quality is evident through adherence to WHO GMP standards, along with EU and USFDA guidelines. They specialize in manufacturing solid dosage forms and have a diverse range of therapeutic areas, although specific details were not provided.